Senova Technology Company Limited sell "Tirzepatide" | Pharmacountry
Packaging: Supplied in gram-scale vials for R&D/formulation use
Regulatory Approval Status: Manufactured under GMP conditions as a registered pharmaceutical intermediate/API; supplied with DMF and Certificate of Analysis support, not marketed as a standalone finished drug product
Indication: Dual GIP/GLP-1 receptor agonist used as an adjunct to diet and exercise for glycemic control in type 2 diabetes and for chronic weight management
Leave your rating & comment